PRECLINICAL DEPRESSION STUDIES
PHARMALEGACY HAS THE EXPERTISE AND MODELS YOU NEED TO ADVANCE YOUR DEPRESSION PROGRAM.
MODELS / SERVICES
Be confident in your preclinical data:
- 600+ NDAs based on PharmaLegacy data
- FDA Part 11 compliant
- Rigorous adherence to international GLP and QA best practices
- AAALAC accredited
- Our scientific staff average 15+ years of experience
Advance your lead depression candidates to NDA with confidence. Contact PharmaLegacy today.
We’re ready when you are.
Tell us your Depression pipeline challenges.
